FDA Drug Application (202626) for ARGATROBAN by MYLAN INSTITUTIONAL

Back to FDA Applications sponsored by MYLAN INSTITUTIONAL

Application Number202626
Product Number001
FormINJECTABLE;INJECTION
Dosage250MG/2.5ML (100MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameARGATROBAN
Active IngredientARGATROBAN

Active IngredientCount
List of drugs with Active Ingredient ARGATROBAN4


Back to FDA Applications sponsored by MYLAN INSTITUTIONAL